The neuromuscular blocking property of amikacin
Hashimoto, Y.; Shima, T.; Matsukawa, S.
Japanese Journal of Antibiotics 30(11): 916-919
1977
ISSN/ISBN: 0368-2781 PMID: 563481 Document Number: 111769
Document emailed within 1 workday
Related Documents
Norman, J. 1979: Neuromuscular blocking drugs British Journal of Anaesthesia 51(6): 471-473Whittaker, R. 1972: On the neuromuscular blocking action of succinylmonocholine in the rat Journal of Pharmacy and Pharmacology 24(4): 340-341
Schuh, F.T. 1981: On the interaction of combinations of nondepolarizing neuromuscular blocking drugs Der Anaesthesist 30(11): 537-542
Sharma, K.K.; Sharma, U.C. 1978: Influence of diazepam on the effect of neuromuscular blocking agents Journal of Pharmacy and Pharmacology 30(1): 64
Fukushima, K.; Aoki, T.; Ishikawa, J. 1984: The influence of verapamil and nifedipine on neuromuscular blocking agents Masui. Japanese Journal of Anesthesiology 33(12): 1346-1350
Gupta, O.P.; Ali, M.M.; Ghatak, B.J.; Atal, C.K. 1977: Neuromuscular blocking activity of a new series of semisynthetic quaternary pyrrolizidines Indian Journal of Medical Research 65(3): 436-440
Andersen, P.T.; Mølgaard, J. 1985: Systemic allergic reactions precipitated by neuromuscular blocking agents Ugeskrift for Laeger 147(51): 4181-4183
Tuba, Z.; Mahó, S. 1992: Synthesis of a new neuromuscular blocking agent, pipecuronium bromide (Arduan) Acta Pharmaceutica Hungarica 62(3): 73-81
Shah, D.S.; Raghunath, P.R.; Gupta, A.K.; Makol, R.; Gulati, O.D. 1974: Neuromuscular blocking action of 2-(2-(3-pyridyl) vinyl)-3-0-tolyl-3, 4-dihydroquinazoline-4-one (SRC 909) Archives Internationales de Pharmacodynamie et de Therapie 209(2): 283-295
Terada, H. 1979: Local anesthetics, neuromuscular blocking agents and excitation inhibition Nihon Rinsho. Japanese Journal of Clinical Medicine 37(7): 2810-2819
Brănişteanu, D.D.; Sauciuc, A.; Proca, B.; Fuică, A.; Gogescu, G. 1982: Mechanisms of the neuromuscular blocking activity of the aminoglycoside antibiotic streptomycin Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 86(2): 287-294
Bellani, P.; Clavenna, G.; Sosio, A. 1984: Synthesis and pharmacological evaluation of imidazopyridinium derivatives as neuromuscular blocking agents Il Farmaco; Edizione Scientifica 39(10): 846-862
Parker, T.S.; Macri, J.R.; Jenden, D.J. 1976: A new neuromuscular blocking agent: 1-methyl, 1(2-hydroxyethyl) aziridinium tosylate (cyclocholine) Proceedings of the Western Pharmacology Society 19: 79-86
Lenart, S.B.; Garrity, J.A. 2000: Eye care for patients receiving neuromuscular blocking agents or propofol during mechanical ventilation American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 9(3): 188-191
Varma, Y.S.; Sharma, P.L. 1971: Clinical experience with pancuronium bromide (NA97): a new steroid neuromuscular blocking agent Indian Journal of Medical Research 59(1): 69-75
Ma, H.; Zhuang, X. 2002: Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia Chinese Medical Journal 115(11): 1692-1696
Okamoto, T.; Aoki, T.; Fukushima, K.; Yoneda, I.; Satoh, T.; Nagashima, H. 1992: Neuromuscular blocking effect of ORG9426, a new non-depolarizing muscle relaxant, and its recovery with various antagonists in vitro Masui. Japanese Journal of Anesthesiology 41(9): 1467-1473
Castles, T.R.; Loth, E.; Crawford, C.R.; Lee, C.C. 1970: The neuromuscular blocking properties of the antimalarial agent, bis((chloro-7"-quinolyl-4")amino-2'-propyl)-1,4-piperazine Journal of Pharmacology and Experimental Therapeutics 172(1): 44-51
Shibuya, N. 1978: A serum factor blocking neuromuscular transmission in myasthenia gravis: electrophysiological study with intracellular microelectrodes Rinsho Shinkeigaku 18(4): 177-184
Simpson, L.L. 1984: The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin Journal of Pharmacology and Experimental Therapeutics 229(1): 182-187